✦ LIBER ✦

A comparison of hippocampal atrophy algorithms to select outcome measures for clinical trials in mild-to-moderate Alzheimer's disease

✍ Scribed by Burns, Leah; Rueckert, Daniel; Bhagwagar, Zubin; Donohue, Michael; Wolz, Robin; Tiller, Jane; Soares, Holly; l'Italien, Gilbert; Coric, Vlad; Hayes, Wendy; Fox, Nick; Berman, Robert

Book ID: 122908623
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 56 KB
Volume: 8
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2012.05.2037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mild to moderate Alzheimer's disease (AD

Mild to moderate Alzheimer's disease (AD) clinical trials: The role of hippocampal atrophy as an inclusion criterion

✍ Robert Risinger; Robert M Berman; Vlad Coric; Jian Han; Stephen Kaplita; Leah Bu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Results of the GAP 160701 study: A phase

Results of the GAP 160701 study: A phase 3 clinical trial of intravenous immunoglobulin for mild-to-moderate Alzheimer's disease

✍ Relkin, Norman 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

P2-260: Misplacing objects in mild to mo

P2-260: Misplacing objects in mild to moderate Alzheimer's disease: A descriptive analysis from the video-imaging synthesis of treating Alzheimer's disease clinical trial

✍ Hamilton, Laura; Fay, Sherri; Rockwood, Kenneth 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Combined treatment with cerebrolysin and

Combined treatment with cerebrolysin and donepezil in mild to moderate alzheimer's disease: Results of a double-blind, randomized clinical trial

✍ Anton Alvarez; Ramon Cacabelos; Manuel Aleixandre; Carlos Linares; Elias Granizo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Correlation of brain atrophy with clinic

Correlation of brain atrophy with clinical progression in mild-to-moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab

✍ Novak, Gerald; Einstein, Steven; Lu, Yuan; Tudor, Iulia Cristina; Gregg, Keith; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Rationale and strategy for thalidomide a

Rationale and strategy for thalidomide as a BACE 1 inhibitor for a phase II randomized clinical trial in mild-to-moderate Alzheimer's disease

✍ Sabbagh, Marwan N.; Nural, Hikmet; He, Ping; Sirrel, Sherye; Belden, Christine; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB